US2022226153A1PendingUtilityA1
Intrascleral shunt placement
Est. expiryDec 8, 2031(~5.4 yrs left)· nominal 20-yr term from priority
A61L 27/222A61L 2430/16A61F 9/0017A61L 27/54A61F 9/00781A61M 37/0069A61L 27/34A61F 9/007
77
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Glaucoma can be treated by implanting an intraocular shunt into an eye. The eye has an anterior chamber and sclera. A shunt can be placed into the eye to establish fluid communication from the anterior chamber of the eye through the sclera, and a pharmaceutical or biological agent can be administered to the eye.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method comprising inserting, through a cornea, an implant in an eye having (i) an anterior chamber and (ii) a sclera, to form a channel through the sclera and thereby establish fluid communication between the anterior chamber and the channel, and administering a pharmaceutical or biological agent to the eye.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.